Interstitial Lung Disease Research Unit Biobank

Description

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

Conditions

Interstitial Lung Disease, Sarcoidosis, Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Hypersensitivity Pneumonitis

Talk to us

Study Overview

On this page

Study Details

Study overview

Establish a interstitial lung disease (ILD) registry and biorepository to lead towards a further understanding of the disease.

University of Kansas Medical Center Interstitial Lung Disease Research Unit (ILDRU) Biobank

Interstitial Lung Disease Research Unit Biobank

Condition
Interstitial Lung Disease
Intervention / Treatment

-

Contacts and Locations

Kansas City

The University of Kansas Medical Center, Kansas City, Kansas, United States, 66160

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • 1. The participant is a patient at TUKHS or has agreed to participate in a study approved by the KUMC Human Research Protection Program (HRPP)
  • 2. The participant is being followed for the presence of autoimmune disease, ILD or other rare lung diseases at TUKHS.
  • 3. The participant is ≥ 18 years of age.
  • 4. The participant has signed an approved consent for this study (living patients only)

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of Kansas Medical Center,

Chase Hall, M.D., PRINCIPAL_INVESTIGATOR, The University of Kansas Medical Center

Study Record Dates

2032-03-01